[Remote] MLS 1 Data Reviewer at Natera

United States

Apply Now

Not SpecifiedCompensation

N/AExperience Level

N/AJob Type

Not SpecifiedVisa

N/AIndustries

Requirements

1-2 years of experience as a Medical Technologist or equivalent in a clinical laboratory environment
BS/BA degree in Medical Technology, Biological Sciences, or a related field
Current MT/MLS/CLS/MB certification preferable from ASCP, AMT, or AAB
Excellent interpersonal, communication, computer, and troubleshooting skills
Experience in Molecular Biology preferred
Excellent oral and written communication skills
Word processing and data management skills
Ability to work well in a group
Ability to work independently, with minimal supervision

Responsibilities

Review clinical test results of molecular genetic testing received from laboratories for accuracy and translate into LIMS
Review and analyze raw data files in proper software and resolve routine issues
Verify the proper specimen analyzed for patients and reviews the test requisition forms to verify the correct tests were performed
Work within several laboratory information systems to review patient demographics and make corrections as needed
Responsible for understanding most current applicable standard operating procedures
Ensures compliance with all regulatory agency requirements through documentation, audits, and corrective action and follows GLP (good laboratory practice)
Given detailed instruction, can complete additional tasks assigned by lead, supervisor, or manager in a timely manner
Comply with all company and department policies and procedures
Works with PHI on a regular basis both in paper and electronic form and has access to various technologies to access PHI in order to perform the job
Complete training relating to HIPAA/PHI privacy, General Policies and Procedure Compliance training and security training as soon as possible but not later than the first 30 days of hire
Maintain a current status on Natera training requirements
Performs other duties as assigned

Skills

Natera

Genetic testing and diagnostics solutions provider

About Natera

Natera focuses on genetic testing and diagnostics, providing advanced solutions for cancer patients, transplant patients, and individuals assessing hereditary health risks. Their main technology is cell-free DNA (cfDNA) testing, which analyzes DNA fragments in the blood to detect minimal traces of cancer and assess organ health. Natera stands out by offering specialized tests like the Signatera ctDNA test and Panorama NIPT, along with genetic counseling services. The company's goal is to improve patient care and health outcomes through accurate genetic testing.

Austin, TexasHeadquarters

2004Year Founded

$149.9MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

1,001-5,000Employees

Benefits

Flexible medical plans

Investment options

Time off

Workplace perks

Risks

Hindenburg report accuses Natera of deceptive sales practices, risking legal challenges.

New Prospera Heart features may face slow adoption by healthcare providers.

Fetal RhD NIPT demand may drop post-RhIg shortage, affecting future sales.

Differentiation

Natera's Signatera test offers personalized ctDNA analysis for cancer patients.

Prospera Heart test uses unique Donor Quantity Score for transplant rejection detection.

Panorama NIPT test is a leader in non-invasive prenatal testing with 2 million tests.

Upsides

Increased adoption of liquid biopsy techniques boosts demand for Natera's cfDNA tests.

AI integration enhances accuracy and speed of Natera's cfDNA analysis.

Growing personalized medicine trend aligns with Natera's customized genetic tests.

Land your dream remote job 3x faster with AI

Try Jobo Free